Individuals who were heterozygous for an MYH mutation were more likely to have an MSI tumour (five of 11, χ2 test P<0.01), whereas one of the cancers seen in the two individuals with biallelic MYH mutations was also MSI (Table 2). This evidence concerns the gene MUTYH and cancer.